ND

Nilesh Dhanwant Sarvaiya

Active Director Director DIN 09704495
DIN 09704495 First appointment Aug 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Nilesh Dhanwant Sarvaiya

Data last updated:

Nilesh Dhanwant Sarvaiya is a Director at Dr. Gabha's World Tour Medical Assistance Private Limited (since 2022). The company operates in Chemicals.

DIN 09704495
Primary Designation Director
Industry Chemicals
First Appointment 16 Aug 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Aug 20222022Active

Directorship timeline

Open interactive timeline →
Dr. Gabha's World Tour Medical Assistance Private Limited
Premium access

Shareholding and investment profile for Nilesh Dhanwant Sarvaiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nilesh Dhanwant Sarvaiya

Nilesh Dhanwant Sarvaiya currently holds 1 directorship: Dr. Gabha's World Tour Medical Assistance Private Limited (Director, since 16 Aug 2022).

Nilesh Dhanwant Sarvaiya was first appointed on 16 Aug 2022 as Director at Dr. Gabha's World Tour Medical Assistance Private Limited.

The current boards of Nilesh Dhanwant Sarvaiya's companies include Sanjay Jotindranath Ghoshdastidar (Dr. Gabha's World Tour Medical Assistance Private Limited), Shanmukh Malineni (Dr. Gabha's World Tour Medical Assistance Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available